Congleton Jon

Chief Executive Officer

Congleton Jon has filed 10 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.

On the most recent filing, Congleton Jon is listed as Chief Executive Officer at Mineralys Therapeutics, Inc. Inside the rolling window, Congleton Jon reported no open-market purchases and 7 open-market sales totaling $16.2M in MLYS. The largest disclosed transaction in the window is a sale of 200,000 MLYS shares on Nov 11, 2025, worth $9.1M.

Companies traded

Other insiders at MLYS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$16.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MLYSSale$1.9MOct 2SEC ↗
MLYSSale$291KJul 16SEC ↗
MLYSSale$2.0MJun 30SEC ↗
MLYSSale$422KApr 15SEC ↗
MLYSSale$2.0MApr 2SEC ↗
MLYSSale$530KJan 13SEC ↗
MLYSSale$9.1MNov 13SEC ↗
Showing 1–7 of 7
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 13, 2025MLYSSale$67K
Oct 13, 2025MLYSSale$578K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Congleton Jon made?

Congleton Jon has filed 10 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.

Which companies does Congleton Jon trade?

Congleton Jon has filed SEC Form 4 disclosures for 1 company, including MLYS.

When was Congleton Jon's most recent SEC Form 4 filing?

Congleton Jon's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.

What is Congleton Jon's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Congleton Jon is listed as Chief Executive Officer.

What is Congleton Jon's total buy and sell value in the current window?

Inside the rolling retention window, Congleton Jon bought $0 and sold $16.2M based on SEC Form 4 filings.

What was Congleton Jon's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 200,000 MLYS shares on 2025-11-11, worth $9.1M, per SEC Form 4 filings.